DXB vs ILA

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

DXB

DIMERIX FPO [DXB]

40LOW

ILA

ISLAND PHA FPO [ILA]

45LOW

Score Breakdown

DXB ILA
Technical
45
73
Catalyst
48
53
Sentiment
50
50
Fundamental
82
39
Momentum
36
57
Risk Gate
50
42

Key Metrics

DXB Metric ILA
$141.1MMarket Cap$146.5M
3.2MAvg Volume (20d)445K
N/AShort InterestN/A
$0.66552-Week High$0.630
$0.15852-Week Low$0.138
+2.1%Daily Change+0.0%
$0.240Reference Price$0.480
-594.5%ROE-130.3%
-219.9%Profit MarginN/A

Active Signals

DXB Signals

Watch out — volume is flowing out even as price holds up. Distribution pattern
Beating the Small Ords index — relative strength of 1.36, so it's outpacing the pack
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
4C filed 2026-04-29
Strong revenue growth (+636%)
EPS estimates revised upward (+10pts)
Near 52-week low (15% of range)

ILA Signals

MACD momentum is picking up steam
Trading above both moving averages — the trend is your friend here
Volume surging at 5.4x normal while price falls — heavy selling pressure
Beating the Small Ords index — relative strength of 1.39, so it's outpacing the pack
Trading above the 200-day average — the long-term trend is on your side
Adequate cash runway (7 quarters)
Very high P/S ratio (2330.6x)
Revenue in sharp decline (-58%)

Ask Scout AI to compare DXB and ILA in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

DXB vs MSB →DXB vs MVF →DXB vs OSL →DXB vs PYC →DXB vs RAC →
DXB Full Analysis → ILA Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).